COc1ccc(-c2cn(-c3ccc(C)cc3)c(=O)n2CC(=O)Nc2cccc(F)c2)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?